Tuesday, June 7, 2016

BRIEF-Pfizer announces positive top-line results from second Phase 3 oral Xeljanz trial

* Pfizer announces positive top-line results from second

phase 3 trial of oral Xeljanz (tofacitinib citrate) in adults

with psoriatic arthritis

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)